MENU
ALZN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alzamend Neuro (ALZN) Earnings Date & Reports
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease... Show more
A.I. Advisor
published Earnings
ALZN is expected to report earnings to fall 66.18% to -23 cents per share on December 08
Q4'26
Est.
$-0.23
Q3'26
Missed
by $0.12
Q2'26
Missed
by $0.30
Q1'26
Missed
by $0.16
Q4'25
Beat
by $0.31
The last earnings report on September 10 showed earnings per share of -68 cents, missing the estimate of -56 cents. With 21.43K shares outstanding, the current market capitalization sits at 5.40M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
3480 Peachtree Road NE
Phone
+1 844 722-6333
Employees
6
Web
https://www.alzamend.com